SUBSCRIBE
SUBSCRIBE

Fate Therapeutics

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
$60 Million Juno Therapeutics Deal Pushes Fate Therapeutics Up 80% in Premarket Trading
May 6, 2015
 · 
7 min read
Load More
AWARDS
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 02, 2024
July 3, 2024
 · 
2 min read
Business
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
June 4, 2024
 · 
3 min read
Biotech Beach
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
May 29, 2024
 · 
1 min read
Business
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
May 9, 2024
 · 
17 min read
Drug Development
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
May 9, 2024
 · 
10 min read
Business
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates
May 6, 2024
 · 
1 min read
Biotech Beach
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
May 3, 2024
 · 
6 min read
Biotech Beach
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
April 22, 2024
 · 
6 min read
Biotech Beach
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
April 3, 2024
 · 
1 min read
Biotech Beach
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - April 02, 2024
April 2, 2024
 · 
2 min read
Load More